Ingenuity Pathway Analysis (IPA)
QIAGEN OmicSoft and Biomedical Knowledge Base
Novel discoveries from public single-cell RNA-seq data using QIAGEN OmicSoft and QIAGEN Ingenuity...
QIAGEN OmicSoft Lands and QIAGEN Ingenuity Pathway Analysis (IPA) provide a...
QIAGEN OMICSOFT AND BIOMEDICAL KNOWLEDGE BASE
QIAGEN OmicSoft and Biomedical Knowledge Base
Biomarkers and drug target investigation using manually curated, unified...
There is an almost incomprehensible amount of diverse, non-standardized ‘omics data...
QIAGEN OmicSoft and Biomedical Knowledge Base
Mining curated knowledge graphs and validating with experimental datasets to...
In an era of near-limitless public experimental data but little standardization,...
QIAGEN OmicSoft and Biomedical Knowledge Base
Identifying critical drug-to-disease pathways using high-quality curated...
In the drug discovery pipeline, evaluating multiple pathways between a drug target and...
QIAGEN OmicSoft and Biomedical Knowledge Base
Discoveries from deeply curated TCGA expression data using OmicSoft Studio
While there is great interest in the scientific community to investigate drug targets...
QIAGEN OmicSoft and Biomedical Knowledge Base
Investigating biomarkers with manually curated RNA-seq expression data
There is a wealth of RNA-seq expression data scattered across public sources like GEO,...
QIAGEN IPA
Discovering and investigating gene signatures for biologists and data scientists
Our high-quality, comprehensive databases are designed for biologists, wet lab...
QIAGEN IPA
Discover biomarkers, validate targets and identify variants with QDI software
Learn how to leverage solutions from QIAGEN Digital Insights to discover biomarkers,...
QIAGEN OmicSoft and Biomedical Knowledge Base
Checkpoint inhibitor and immuno-oncology investigation leveraging curated...
While there is great interest in the scientific community to investigate drug targets...
QIAGEN OmicSoft and Biomedical Knowledge Base
Gene therapy applications through knowledge graph explorations
In gene therapy space, there is great interest in discovering new gene editing targets...